Again, I can only speak to that to the extent that what has been effective, has been effective when it has been used. It took a very short time, as we've talked about. I can't speak to why other countries have not used it. You can postulate around it: is it an issue of voluntary licences, partnerships that are being developed elsewhere? Is it a question that the price is coming out of Indian, Brazilian, and South African generics that are substantially lower than Canada's, or is it our ease of access? There are a number of factors that contribute to it, but with a lack of attempt to use it, it indicates to me there's a lack of need for that particular piece of legislation. It does not mean there's a lack of need to meet humanitarian goals in the developing world, but if they're not accessing the legislation, I can't speak to why not.
On October 26th, 2010. See this statement in context.